Significant antitumour effect of an antibody against TMEM180, a new cancer-specific molecule

作者: Masahiro Yasunaga , Shinji Saijou , Shingo Hanaoka , Takahiro Anzai , Ryo Tsumura

DOI: 10.1101/397844

关键词:

摘要: The present state of therapy for colorectal cancer (CRC) is far from satisfactory, highlighting the need new targets this disease. We identified a (CRC)-specific molecule, TMEM180, predicted eleven-pass transmembrane protein that apparently functions as cation symporter. Our anti-TMEM180 monoclonal antibody (mAb) eradicated SW480 CRC xenografts in mice. TMEM180 promoter region contains ten hypoxia-responsive element consensus sequences; accordingly cells upregulated under low-oxygen conditions. expression was positively correlated with anchorage-independent colony formation and tumourigenesis. TMEM180-positive resided at tumour-stroma interface manifested by αSMA-positive fibroblasts, also known tumour niche. Some clusters adjacent to niche were integrin α6-positive. These data indicate represents possible stem cell marker mAb against could be used antibody-based therapeutic CRC.

参考文章(51)
Robert P Lyon, Tim D Bovee, Svetlana O Doronina, Patrick J Burke, Joshua H Hunter, Haley D Neff-LaFord, Mechthild Jonas, Martha E Anderson, Jocelyn R Setter, Peter D Senter, Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index. Nature Biotechnology. ,vol. 33, pp. 733- 735 ,(2015) , 10.1038/NBT.3212
Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang, Steven C. Clifford, Emma C. Vaux, Matthew E. Cockman, Charles C. Wykoff, Christopher W. Pugh, Eamonn R. Maher, Peter J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature. ,vol. 399, pp. 271- 275 ,(1999) , 10.1038/20459
Yilei Gong, Weiqi Tan, Jie Lin, Maosheng Huang, Christopher G. Wood, Xifeng Wu, Abstract 4640: Quantification of gamma-H2AX expression in whole blood culture as a risk predictor for renal cell carcinoma Cancer Research. ,vol. 71, pp. 4640- 4640 ,(2011) , 10.1158/1538-7445.AM2011-4640
Masahiro Yasunaga, Shinsuke Tada, Satomi Torikai-Nishikawa, Yoko Nakano, Mitsuhiro Okada, Lars Martin Jakt, Satomi Nishikawa, Tsutomu Chiba, Takumi Era, Shin-Ichi Nishikawa, Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells Nature Biotechnology. ,vol. 23, pp. 1542- 1550 ,(2005) , 10.1038/NBT1167
J. W. Gordon, G. A. Scangos, D. J. Plotkin, J. A. Barbosa, F. H. Ruddle, Genetic transformation of mouse embryos by microinjection of purified DNA. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 77, pp. 7380- 7384 ,(1980) , 10.1073/PNAS.77.12.7380
Masahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura, New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clots Cancer Science. ,vol. 102, pp. 1396- 1402 ,(2011) , 10.1111/J.1349-7006.2011.01954.X
Marc Damelin, Wenyan Zhong, Jeremy Myers, Puja Sapra, Evolving Strategies for Target Selection for Antibody-Drug Conjugates Pharmaceutical Research. ,vol. 32, pp. 3494- 3507 ,(2015) , 10.1007/S11095-015-1624-3
T Barrette, A Pandey, AM Chinnaiyan, ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform Neoplasia. ,vol. 6, pp. 1- 6 ,(2004) , 10.1016/S1476-5586(04)80047-2
Chunping Wu, Allison L. Dill, Livia S. Eberlin, R. Graham Cooks, Demian R. Ifa, Mass spectrometry imaging under ambient conditions. Mass Spectrometry Reviews. ,vol. 32, pp. 218- 243 ,(2013) , 10.1002/MAS.21360